Nurix Therapeutics Reveals 2025 Financials And Corporate Update
28 Jan 2026 //
GLOBENEWSWIRE
Nurix Therapeutics Sets 2026 Goals For Advancing Bexobrutideg
12 Jan 2026 //
GLOBENEWSWIRE
Nurix Presents Bexobrutideg Data in Waldenström at ASH
08 Dec 2025 //
GLOBENEWSWIRE
Nurix Shows Strong Responses In Phase 1 Bexobrutideg Trial
06 Dec 2025 //
GLOBENEWSWIRE
Nurix Therapeutics To Present Phase 1 Bexobrutideg Data At ASH
01 Dec 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support